Similar effects on asthma were observed by Zhou et al., by treating OVA-induced mice with EA (10 mg/kg, p.o.): the compound was shown to impair lung eosinophilia and Th2 cytokines and to counteract NF-κB activation in the respiratory tissue [104]. The gene discussed is NFKB1; the disease is asthma.